Characteristics of Crohn’s disease patients treated with Infliximab and their Crohn’s disease controls who never received Infliximab, not including matched variables
| Characteristic | Infliximab treated patients (n (%)) | Control patients (n (%)) |
|---|---|---|
| †Median (range). | ||
| IBD, inflammatory bowel disease. | ||
| *p = 0.042, stricturing CD in controls who had never received Infliximab versus Infliximab treated patients. | ||
| **p = 0.003, fistulising CD in Infliximab treated patients versus controls who had never received Infliximab. | ||
| Crohn’s disease type | ||
| Inflammatory | 146 (36%) | 177 (44%) |
| Fistulising | 238 (59%)** | 175 (43%) |
| Stricturing | 20 (5%) | 52 (13%)* |
| Familial IBD | ||
| No | 361 (89%) | 360 (89%) |
| Yes | 43 (11%) | 44 (11%) |
| Smoking habits | ||
| Yes | 144 (36%) | 144 (36%) |
| No | 223 (55%) | 216 (53%) |
| Ex | 37 (9%) | 44 (11%) |
| Previous surgery | ||
| Yes | 157 (39%) | 178 (44%) |
| No | 247 (61%) | 226 (56%) |
| Age at Crohn’s disease diagnosis (y)† | 28 (7–80) | 29 (9–81) |